IHS Chemical Week

People & Business :: Emerging Companies

Enzon Pharmaceuticals to Spin Off Unit

10:56 AM MDT | May 20, 2008 | Deepti Ramesh

Enzon Pharmaceuticals (Bridgewater, NJ) says it plans to spin off its novel biotechnology business to create separate biotechnology and speciality pharmaceutical public companies. The transaction is expected to be completed in the fourth quarter. “The opportunities for both the specialty pharmaceutical business and the biotechnology business could be substantially enhanced, and greater value could be created than under the current structure,” says Jeffrey Buchalter, chairman, president, and CEO of Enzon. “Operating separately will allow each...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa